<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[MedImmune Inc. | Company News & Executive Profiles | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/medimmune+inc..html?i=3]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for MedImmune Inc.]]></description>
	<s:counts start="0" returned="10" found="276" />
	<language>en-us</language>
	<item>
		<title><![CDATA[DotW: Sesame Street]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/dotw-sesame-street/19334/]]></link>
		<description><![CDATA[In case you failed to run a Google search this week, you may not have realized that on Tuesday Nov. 10, Sesame Street turns 40. You gotta admit, the show doesn't look a day over five--and that's without Botox.If you've forgotten how to get to Sesame Street, we have a...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Fri, 06 Nov 2009 08:36:19 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/development.html"><![CDATA[Development]]></category>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Infinity and AstraZeneca Split, Schering & Merck's PR Blunder, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000492/pharma-roundup-infinity-and-astrazeneca-split-schering-mercks-pr-blunder-and-more/]]></link>
		<description><![CDATA[A fond farewell between Infinity and AstraZeneca, a dubious PR honor for S-P and Merck over Vytorin, Lilly's ImClone-related costs mount, generics cost less. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Thu, 11 Dec 2008 17:02:22 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/public+relations.html"><![CDATA[Public Relations]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+communications.html"><![CDATA[Corporate Communications]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">AZN,MRK</category>
	</item>
	<item>
		<title><![CDATA[How Not to Do An Acquisition: AstraZeneca-MedImmune]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000121/how-not-to-do-an-acquisition-astrazeneca-medimmune/]]></link>
		<description><![CDATA[When AstraZeneca ponied up more than $15 billion for the biotech MedImmune just over a year ago, the deal suggested that desperate Big Pharmas were willing to open their wallets wide for biotechs without looking too closely into the question of whether they were really worth the money. As I...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Thu, 10 Jul 2008 05:10:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/acquisition.html"><![CDATA[Acquisition]]></category>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[DIREVO announces transfer of patents from Evotec]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200807/ai_n27898531]]></link>
		<description><![CDATA[DIREVO Biotech AG announced today that it has entered into an agreement with Evotec under which Evotec will transfer certain patents to DIREVO that are currently licensed by DIREVO. Such patents protect key components of DIREVO's unique and proven protein/strain engineering platform. Using this platform, DIREVO develops products both independently...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 09 Jul 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nestle+s.a..html"><![CDATA[Nestle S.A.]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[Hiring underway at Gaithersburg-based MedImmune]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4183/is_20080606/ai_n25503826]]></link>
		<description><![CDATA[MedImmune Inc., of Gaithersburg, a biotechnology company focused on developing and manufacturing products to combat infectious disease, autoimmune disease and cancer, announced that it is looking to fill more than 800 jobs, mostly in research and development and clinical positions, by the end of the year, expanding its work force...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 06 Jun 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/hiring.html"><![CDATA[hiring]]></category>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[News Summary - 4/16]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4183/is_20080416/ai_n25164881]]></link>
		<description><![CDATA[United BioSource acquisition   United BioSource Corp., of Bethesda, a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products, announced its acquisition of Envision Pharma, a scientific communications and technology company based in Horsham, U.K., with offices in Southport and Glastonbury,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 16 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/baltimore.html"><![CDATA[Baltimore]]></category>
		<category domain="http://resources.bnet.com/topic/bank.html"><![CDATA[bank]]></category>
		<category domain="http://resources.bnet.com/topic/harassment.html"><![CDATA[Harassment]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/hilton+hotels+corp..html"><![CDATA[Hilton Hotels Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/washington.html"><![CDATA[Washington]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HLT</category>
		<category domain="tickers">HLT</category>
	</item>
	<item>
		<title><![CDATA[Gaithersburg-based MedImmune drug advances]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn4183/is_20080416/ai_n25164945]]></link>
		<description><![CDATA[MedImmune Inc., of Gaithersburg, a biotechnology company focused on developing and manufacturing products to combat infectious disease, autoimmune disease and cancer, announced the start of two new clinical trials as part of its efforts to develop CAT-354, an antibody that MedImmune sees as a potential treatment for patients with asthma....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 16 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Pinnacle Biologics Announces Marketing and Distribution Agreement With MedImmune.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200802/ai_n25295988]]></link>
		<description><![CDATA[ROCKVILLE, Maryland, February 19 /PRNewswire/ --     ROCKVILLE, Maryland, February 19 /PRNewswire/ --   ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 19 Feb 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[MedImmune Submits Biologics License Application to FDA for Motavizumab.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200802/ai_n25295507]]></link>
		<description><![CDATA[GAITHERSBURG, Maryland, February 4 /PRNewswire/ --     GAITHERSBURG, Maryland, February 4 /PRNewswire/ --   ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 04 Feb 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Research and Markets: SWOT Analysis Tool to Evaluate the Strengths, Weaknesses, Opportunities, and Threats of MedImmune]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Jan_16/ai_n24229819]]></link>
		<description><![CDATA[DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c79606) has announced the addition of "MedImmune - SWOT Framework Analysis" to their offering.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 16 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/swot+analysis.html"><![CDATA[SWOT analysis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
